{"id":18664,"date":"2022-01-17T10:18:04","date_gmt":"2022-01-17T02:18:04","guid":{"rendered":"https:\/\/tbenews.com\/tbe\/?p=18664"},"modified":"2022-01-17T10:18:04","modified_gmt":"2022-01-17T02:18:04","slug":"snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland","status":"publish","type":"post","link":"https:\/\/tbenews.com\/tbe\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\/","title":{"rendered":"Snapshot week 3\/2022<br>TBE vaccine coverage in Switzerland"},"content":{"rendered":"<span class=\"cb-itemprop\" itemprop=\"reviewBody\">\n<p class=\"wp-block-paragraph\">Zens et al.<br>A cross-sectional study evaluating tick-borne encephalitis vaccine uptake and timeliness among adults in Switzerland<br><em>PLoS ONE<\/em>. 2021, 16(12): e0247216. doi: 10.1371\/journal.pone.0247216<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A national, cross-sectional study (based on obtaining vaccination records by mail) has been carried out to evaluate timeliness of TBE vaccination in Switzerland. Of 4,626 participants, 1875 individuals had at least one TBE vaccination. Mean age of first vaccination was 37. Of those having received a first injection, 96% of individuals received a second dose, and 82% of these individuals also received a third dose.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Among those vaccinees receiving three doses, 29% received Encepur (based on strain K239), 59% received FSME Immun (based on strain Neud\u00f6rfl) and 12% received a combination of these vaccines. Only 5% of the individuals were vaccinated by a rapid vaccination scheme. Most individuals received the conventional scheme of whom 88% received the second dose on time and 78% received the third dose on time. Of those receiving Encepur, 21% received the third dose too early according to the package leaflet (only 6% of those vaccinated with FSME Immun).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">31% of those with a complete primary vaccination received one or more booster dose(s). The median time for the first booster was 7.3 years and for the second booster was 4.0 years after the first booster dose.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">About 25% of adults received their first vaccination aged 50+, and 20% of Swiss adults beginning with the primary vaccination course only received a first dose. However, in general the vaccination coverage among adults was higher compared to many other European countries (e.g., Germany, see <a href=\"https:\/\/tbenews.com\/tbe\/snapshot-week-1-2022low-vaccination-rates-in-adults-in-germanys-tbe-risk-areas\/\" data-type=\"URL\" data-id=\"https:\/\/tbenews.com\/tbe\/snapshot-week-1-2022low-vaccination-rates-in-adults-in-germanys-tbe-risk-areas\/\">Snapshot week 1\/2022<\/a>, <a href=\"https:\/\/tbenews.com\/tbe\/snapshot-week-3-2021tbe-vaccination-coverage-in-germany\/\" data-type=\"URL\" data-id=\"https:\/\/tbenews.com\/tbe\/snapshot-week-3-2021tbe-vaccination-coverage-in-germany\/\">Snapshot week 3\/2021<\/a>).<\/p>\n<\/span>","protected":false},"excerpt":{"rendered":"<p>Zens et al.A cross-sectional study evaluating tick-borne encephalitis vaccine uptake and timeliness among adults in SwitzerlandPLoS ONE. 2021, 16(12): e0247216. doi: 10.1371\/journal.pone.0247216 A national, cross-sectional study (based on obtaining vaccination records by mail) has been carried out to evaluate timeliness of TBE vaccination in Switzerland. Of 4,626 participants, 1875 individuals had at least one TBE vaccination. Mean age of first vaccination was 37. Of those having received a first injection, 96% of individuals received a second dose, and 82% of these individuals also received a third dose. Among those vaccinees receiving three doses, 29% received Encepur (based on strain K239), 59% received FSME Immun (based on strain Neud\u00f6rfl) and 12% received a combination of these vaccines. Only 5% of the individuals were vaccinated by a rapid vaccination scheme. Most individuals received the conventional scheme of whom 88% received the second dose on time and 78% received the third dose on time. Of those receiving Encepur, 21% received the third dose too early according to the package leaflet (only 6% of those vaccinated with FSME Immun). 31% of those with a complete primary vaccination received one or more booster dose(s). The median time for the first booster was 7.3 years and for the second booster was 4.0 years after the first booster dose. About 25% of adults received their first vaccination aged 50+, and 20% of Swiss adults beginning with the primary vaccination course only received a first dose. However, in general the vaccination coverage among adults was higher compared to many other European countries (e.g., Germany, see Snapshot week 1\/2022, Snapshot week 3\/2021).<\/p>\n","protected":false},"author":1354,"featured_media":12864,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[18],"tags":[211,849,850,228,239],"coauthors":[581],"class_list":["post-18664","post","type-post","status-publish","format-standard","has-post-thumbnail","category-snapshot","tag-booster-dose","tag-conventional-scheme","tag-rapid-scheme","tag-switzerland","tag-vaccination-coverage"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Snapshot week 3\/2022TBE vaccine coverage in Switzerland - TBE Book<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tbenews.com\/tbe\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Snapshot week 3\/2022TBE vaccine coverage in Switzerland - TBE Book\" \/>\n<meta property=\"og:description\" content=\"Zens et al.A cross-sectional study evaluating tick-borne encephalitis vaccine uptake and timeliness among adults in SwitzerlandPLoS ONE. 2021, 16(12): e0247216. doi: 10.1371\/journal.pone.0247216 A national, cross-sectional study (based on obtaining vaccination records by mail) has been carried out to evaluate timeliness of TBE vaccination in Switzerland. Of 4,626 participants, 1875 individuals had at least one TBE vaccination. Mean age of first vaccination was 37. Of those having received a first injection, 96% of individuals received a second dose, and 82% of these individuals also received a third dose. Among those vaccinees receiving three doses, 29% received Encepur (based on strain K239), 59% received FSME Immun (based on strain Neud\u00f6rfl) and 12% received a combination of these vaccines. Only 5% of the individuals were vaccinated by a rapid vaccination scheme. Most individuals received the conventional scheme of whom 88% received the second dose on time and 78% received the third dose on time. Of those receiving Encepur, 21% received the third dose too early according to the package leaflet (only 6% of those vaccinated with FSME Immun). 31% of those with a complete primary vaccination received one or more booster dose(s). The median time for the first booster was 7.3 years and for the second booster was 4.0 years after the first booster dose. About 25% of adults received their first vaccination aged 50+, and 20% of Swiss adults beginning with the primary vaccination course only received a first dose. However, in general the vaccination coverage among adults was higher compared to many other European countries (e.g., Germany, see Snapshot week 1\/2022, Snapshot week 3\/2021).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tbenews.com\/tbe\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\/\" \/>\n<meta property=\"og:site_name\" content=\"TBE Book\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-17T02:18:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2017\/11\/TBE-Snapshots.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"250\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Shaqeez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Shaqeez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\\\/\"},\"author\":{\"name\":\"Shaqeez\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#\\\/schema\\\/person\\\/2bc2ab1f56f93257537a0ce8de903224\"},\"headline\":\"Snapshot week 3\\\/2022 TBE vaccine coverage in Switzerland\",\"datePublished\":\"2022-01-17T02:18:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\\\/\"},\"wordCount\":253,\"publisher\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/wp-content\\\/uploads\\\/2017\\\/11\\\/TBE-Snapshots.jpg\",\"keywords\":[\"booster dose\",\"conventional scheme\",\"rapid scheme\",\"Switzerland\",\"vaccination coverage\"],\"articleSection\":[\"Snapshot\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\\\/\",\"url\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\\\/\",\"name\":\"Snapshot week 3\\\/2022 TBE vaccine coverage in Switzerland - TBE Book\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/wp-content\\\/uploads\\\/2017\\\/11\\\/TBE-Snapshots.jpg\",\"datePublished\":\"2022-01-17T02:18:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\\\/#primaryimage\",\"url\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/wp-content\\\/uploads\\\/2017\\\/11\\\/TBE-Snapshots.jpg\",\"contentUrl\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/wp-content\\\/uploads\\\/2017\\\/11\\\/TBE-Snapshots.jpg\",\"width\":1180,\"height\":250},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Snapshot week 3\\\/2022TBE vaccine coverage in Switzerland\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#website\",\"url\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/\",\"name\":\"The TBE Book\",\"description\":\"Tick-borne Encephalitis (TBE)\",\"publisher\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#organization\",\"name\":\"Global Health Press\",\"url\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/wp-content\\\/uploads\\\/2019\\\/01\\\/logo-PNG.png\",\"contentUrl\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/wp-content\\\/uploads\\\/2019\\\/01\\\/logo-PNG.png\",\"width\":1000,\"height\":715,\"caption\":\"Global Health Press\"},\"image\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#\\\/schema\\\/person\\\/2bc2ab1f56f93257537a0ce8de903224\",\"name\":\"Shaqeez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f1c6a04352cef6bb74d75fceabfabb30473aa9958d64ddd93f1feaec90954df3?s=96&d=mm&r=g2ce4daa834e38f5ff18a9faa82d1596d\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f1c6a04352cef6bb74d75fceabfabb30473aa9958d64ddd93f1feaec90954df3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f1c6a04352cef6bb74d75fceabfabb30473aa9958d64ddd93f1feaec90954df3?s=96&d=mm&r=g\",\"caption\":\"Shaqeez\"},\"url\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/author\\\/shaqeez\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Snapshot week 3\/2022TBE vaccine coverage in Switzerland - TBE Book","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tbenews.com\/tbe\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\/","og_locale":"en_US","og_type":"article","og_title":"Snapshot week 3\/2022TBE vaccine coverage in Switzerland - TBE Book","og_description":"Zens et al.A cross-sectional study evaluating tick-borne encephalitis vaccine uptake and timeliness among adults in SwitzerlandPLoS ONE. 2021, 16(12): e0247216. doi: 10.1371\/journal.pone.0247216 A national, cross-sectional study (based on obtaining vaccination records by mail) has been carried out to evaluate timeliness of TBE vaccination in Switzerland. Of 4,626 participants, 1875 individuals had at least one TBE vaccination. Mean age of first vaccination was 37. Of those having received a first injection, 96% of individuals received a second dose, and 82% of these individuals also received a third dose. Among those vaccinees receiving three doses, 29% received Encepur (based on strain K239), 59% received FSME Immun (based on strain Neud\u00f6rfl) and 12% received a combination of these vaccines. Only 5% of the individuals were vaccinated by a rapid vaccination scheme. Most individuals received the conventional scheme of whom 88% received the second dose on time and 78% received the third dose on time. Of those receiving Encepur, 21% received the third dose too early according to the package leaflet (only 6% of those vaccinated with FSME Immun). 31% of those with a complete primary vaccination received one or more booster dose(s). The median time for the first booster was 7.3 years and for the second booster was 4.0 years after the first booster dose. About 25% of adults received their first vaccination aged 50+, and 20% of Swiss adults beginning with the primary vaccination course only received a first dose. However, in general the vaccination coverage among adults was higher compared to many other European countries (e.g., Germany, see Snapshot week 1\/2022, Snapshot week 3\/2021).","og_url":"https:\/\/tbenews.com\/tbe\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\/","og_site_name":"TBE Book","article_published_time":"2022-01-17T02:18:04+00:00","og_image":[{"width":1180,"height":250,"url":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2017\/11\/TBE-Snapshots.jpg","type":"image\/jpeg"}],"author":"Shaqeez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Shaqeez","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\/#article","isPartOf":{"@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\/"},"author":{"name":"Shaqeez","@id":"https:\/\/tbenews.com\/tbe\/#\/schema\/person\/2bc2ab1f56f93257537a0ce8de903224"},"headline":"Snapshot week 3\/2022 TBE vaccine coverage in Switzerland","datePublished":"2022-01-17T02:18:04+00:00","mainEntityOfPage":{"@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\/"},"wordCount":253,"publisher":{"@id":"https:\/\/tbenews.com\/tbe\/#organization"},"image":{"@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\/#primaryimage"},"thumbnailUrl":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2017\/11\/TBE-Snapshots.jpg","keywords":["booster dose","conventional scheme","rapid scheme","Switzerland","vaccination coverage"],"articleSection":["Snapshot"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\/","url":"https:\/\/tbenews.com\/tbe\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\/","name":"Snapshot week 3\/2022 TBE vaccine coverage in Switzerland - TBE Book","isPartOf":{"@id":"https:\/\/tbenews.com\/tbe\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\/#primaryimage"},"image":{"@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\/#primaryimage"},"thumbnailUrl":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2017\/11\/TBE-Snapshots.jpg","datePublished":"2022-01-17T02:18:04+00:00","breadcrumb":{"@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tbenews.com\/tbe\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\/#primaryimage","url":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2017\/11\/TBE-Snapshots.jpg","contentUrl":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2017\/11\/TBE-Snapshots.jpg","width":1180,"height":250},{"@type":"BreadcrumbList","@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-3-2022tbe-vaccine-coverage-in-switzerland\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tbenews.com\/tbe\/"},{"@type":"ListItem","position":2,"name":"Snapshot week 3\/2022TBE vaccine coverage in Switzerland"}]},{"@type":"WebSite","@id":"https:\/\/tbenews.com\/tbe\/#website","url":"https:\/\/tbenews.com\/tbe\/","name":"The TBE Book","description":"Tick-borne Encephalitis (TBE)","publisher":{"@id":"https:\/\/tbenews.com\/tbe\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tbenews.com\/tbe\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/tbenews.com\/tbe\/#organization","name":"Global Health Press","url":"https:\/\/tbenews.com\/tbe\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tbenews.com\/tbe\/#\/schema\/logo\/image\/","url":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2019\/01\/logo-PNG.png","contentUrl":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2019\/01\/logo-PNG.png","width":1000,"height":715,"caption":"Global Health Press"},"image":{"@id":"https:\/\/tbenews.com\/tbe\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/tbenews.com\/tbe\/#\/schema\/person\/2bc2ab1f56f93257537a0ce8de903224","name":"Shaqeez","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f1c6a04352cef6bb74d75fceabfabb30473aa9958d64ddd93f1feaec90954df3?s=96&d=mm&r=g2ce4daa834e38f5ff18a9faa82d1596d","url":"https:\/\/secure.gravatar.com\/avatar\/f1c6a04352cef6bb74d75fceabfabb30473aa9958d64ddd93f1feaec90954df3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f1c6a04352cef6bb74d75fceabfabb30473aa9958d64ddd93f1feaec90954df3?s=96&d=mm&r=g","caption":"Shaqeez"},"url":"https:\/\/tbenews.com\/tbe\/author\/shaqeez\/"}]}},"_links":{"self":[{"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/posts\/18664","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/users\/1354"}],"replies":[{"embeddable":true,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/comments?post=18664"}],"version-history":[{"count":1,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/posts\/18664\/revisions"}],"predecessor-version":[{"id":18665,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/posts\/18664\/revisions\/18665"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/media\/12864"}],"wp:attachment":[{"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/media?parent=18664"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/categories?post=18664"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/tags?post=18664"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/coauthors?post=18664"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}